返回结果列表    添加到电子书架    保存/邮寄    荐购此文献    重新查询
第 1 条记录(共 1 条)      
系统号-图书   000647603
ISBN   Link9781421414935
  Link1421414937
LC索书号   RM301 .G74 2014
中图分类号   LinkR92-09
个人著者   LinkGreene, Jeremy A., 1974- author
题名   LinkGeneric : the unbranding of modern medicine / Jeremy A. Greene
出版发行   LinkJohn Hopkins University Press, 2014年.
载体形态   xii, 354 pages : illustrations ; 24 cm
书目附注   Includes bibliographical references and index
格式化内容附   Contents: Introduction: The same but not the same -- What’s in a name? -- No such thing as a generic drug? -- The sciences of similarity -- Laws of substitution -- Paradoxes of generic consumption -- The generic alternative
摘要   Generic drugs are now familiar objects in clinics, drugstores, and households around the world. We like to think of these tablets, capsules, patches, and ointments as interchangeable with their brand-name counterparts: why pay more for the same? And yet they are not quite the same. They differ in price, in place of origin, in color, shape, and size, in the dyes, binders, fillers, and coatings used, and in a host of other ways. Claims of generic equivalence, as physician-historian Jeremy Greene reveals, are never based on being identical to the original drug in all respects, but in being the same in all ways that matter. How do we know what parts of a pill really matter? Decisions about which differences are significant and which are trivial in the world of therapeutics are not resolved by simple chemical or biological assays alone. 
  Questions of therapeutic similarity and difference are also always questions of pharmacology and physiology, of economics and politics, of morality and belief. Greene chronicles the social, political, and cultural history of generic drugs, narrating the evolution of the generic drug industry from a set of mid-twentieth-century "schlock houses" and "counterfeiters" into an agile and surprisingly powerful set of multinational corporations in the early twenty-first century. The substitution of bioequivalent generic drugs for more expensive brand-name products is a rare success story in a field of failed attempts to deliver equivalent value in health care for a lower price. 
  Greene’s history sheds light on the controversies shadowing the success of generics: problems with the generalizability of medical knowledge, the fragile role of science in public policy, and the increasing role of industry, marketing, and consumer logics in late-twentieth-century and early twenty-first century health care
LC附加主题   LinkGeneric drugs -- History
  LinkPharmaceutical industry -- History
MeSH附加主题   LinkDrugs, Generic -- history
  LinkDrug Industry -- history
  LinkHistory, 20th Century
  LinkHistory, 21st Century
 
 
全部馆藏   所有单册
  


     


结束会话 - 参数设置 - 反馈意见 - 帮助 - 馆际互借 - Ex Libris - 浏览 - 查找 - 结果列表 - 以往检索结果 - 数据库